Resultats globals: 1 registres trobats en 0.01 segons.
Articles, 1 registres trobats
Articles 1 registres trobats  
1.
1 p, 297.1 KB Erratum to : Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma / Wong, Deborah J. L. (Department of Medicine. Division of Hematology-Oncology. University of California) ; Robert, Lidia (Universitat Autònoma de Barcelona) ; Atefi, Mohammad S. (Department of Medicine. Division of Hematology-Oncology. University of California) ; Lassen, Amanda (Department of Medicine. Division of Hematology-Oncology. University of California) ; Avarappatt, Geetha (University of Applied Sciences. Austria) ; Cerniglia, Michael (Department of Medicine. Division of Hematology-Oncology. University of California) ; Avramis, Earl (Department of Medicine. Division of Hematology-Oncology. University of California) ; Tsoi, Jennifer (Department of Molecular and Medical Pharmacology. UCLA. USA) ; Foulad, David (Department of Medicine. Division of Hematology-Oncology. University of California) ; Graeber, Thomas G. (Department of Molecular and Medical Pharmacology. UCLA. USA) ; Comin-Anduix, Begonya (Jonsson Comprehensive Cancer Center. UCLA. USA.) ; Samatar, Ahmed (Discovery Oncology Merck Research Laboratories. Merck Research Laboratories. Boston. USA) ; Lo, Roger S. (Department of Medicine. Division of Dermatology. UCLA. USA) ; Ribas, Antoni (Jonsson Comprehensive Cancer Center. UCLA. USA)
After publication of this work [1], we noted that we repeatedly had a typo mistake across the manuscript. The compound we used to test our cell lines was SCH772984 and not SCH722984. The typo was found misspelled in 54 occasions, including the title. [...]
2015 - 10.1186/s12943-015-0393-2
Molecular cancer, Vol. 14 (July 2015)  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.